榮泰健康(603579.SH)擬6000萬元募集資金向浙江榮泰增資
格隆匯12月8日丨榮泰健康(603579.SH)公佈,公司擬使用公開發行可轉換公司債券募集資金總計6000萬元對全資子公司浙江榮泰進行增資,其中1000萬元作為浙江榮泰的新增註冊資本,剩餘部分計入資本公積。增資完成後,浙江榮泰按照募集資金使用計劃用於“浙江湖州南潯榮泰按摩椅製造基地項目”。本次增資後,浙江榮泰的註冊資本由7000萬元增加至8000萬元,浙江榮泰仍為公司持股100%的全資子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.